Abpro Holdings (ABPO) Payables (2021 - 2026)
Abpro Holdings' (ABPO) quarterly Payables came in at $5.2 million in Q1 2026, down 30.1% YoY from $7.5 million in Q1 2025, and down 4.1% on a QoQ basis from $5.5 million in Q4 2025.
Abpro Holdings (ABPO) Payables (2021 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Payables data on file, last reported at $5.2 million in Q1 2026.
- Quarterly Payables fell 30.1% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 30.1% YoY) and the FY2025 annual result came in at $5.5 million, up 27.15% from the prior year.
- Payables fell to $5.2 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $9.7 million in Q4 2023 to a low of $1.5 million in Q1 2024.
- A 4-year average of $4.8 million and a median of $5.1 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables tumbled 55.46% — and 2025, when it surged 393.52%.
- Tracing ABPO's Payables over 4 years: stood at $9.7 million in 2023, then plunged by 55.46% to $4.3 million in 2024, then climbed by 27.15% to $5.5 million in 2025, then fell by 4.1% to $5.2 million in 2026.
- The last three Payables figures came in at $5.2 million (Q1 2026), $5.5 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | 4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.25 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 7.51 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Dec 31, 2021 | 100,277.00 |